Nishimura H

No ORCID on file · 4 papers in corpus · active 1988-2009

Study types

  • other 2
  • article 1

Condition tags

  • endometriosis 3
2009
Isoflavone, polymorphisms in estrogen receptor genes and breast cancer risk in case-control studies in Japanese, Japanese Brazilians and non-Japanese Brazilians.
Cancer science ·doi:10.1111/j.1349-7006.2009.01118.x

Epidemiologic studies have shown an inverse association between isoflavones and breast cancer risk. Because isoflavones bind estrogen receptors, we hypothesized that polymorphisms in the estrogen receptor genes might modify the association …

article 1994
[Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis].
Gan to kagaku ryoho. Cancer & chemotherapy

We examined GAT, a newly developed tumor marker, in serum samples collected from 1,503 females in six institutions: 387 healthy females, 1,052 patients with gynecological diseases including 311 ovarian cancers, and 64 with nongynecological …

other 1992
Significance of the serum CA125 level in recurrent ovarian cancer
Asia-Oceania journal of obstetrics and gynaecology ·doi:10.1111/j.1447-0756.1992.tb00297.x

Thirty-four recurrent cases of 89 patients with ovarian cancer treated in our department between 1985 and 1989 were examined for changes in serum CA125 level. 1) Upon confirmation of recurrence, 17 patients were positive for CA125 and 15 we…

other 1988
[Phase II study of carboplatin in ovarian cancer]
Gan to kagaku ryoho. Cancer & chemotherapy

A phase II study of carboplatin was conducted in ovarian cancer by a cooperative study group consisting of 22 institutions nationwide. The overall response rate of 50 evaluable cases was 38.0%. The response rate in cases with no prior chemo…